Skip to main content
HR 6190 112th Congress House Environmental Protection Administrative law and regulatory procedures Air quality Cardiovascular and respiratory health Climate change and greenhouse gases Environmental Protection Agency (EPA) Environmental regulatory procedures Health technology, devices, supplies

Asthma Inhalers Relief Act of 2012

Introduced: July 25, 2012 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 12 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 12, 2012
Mr. Burgess moved to suspend the rules and pass the bill.
Dec 12, 2012
On motion to suspend the rules and pass the bill Failed by the Yeas and Nays: (2/3 required): 229 - 182 (Roll no. 623).
Dec 12, 2012
Failed of passage/not agreed to in House: On motion to suspend the rules and pass the bill Failed by the Yeas and Nays: (2/3 required): 229 - 182 (Roll no. 623).
Dec 12, 2012
Considered as unfinished business. (consideration: CR H6740-6741)
Dec 12, 2012
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Dec 12, 2012
DEBATE - The House proceeded with forty minutes of debate on H.R. 6190.
Dec 12, 2012
Considered under suspension of the rules. (consideration: CR H6724-6728; text of measure as reported in House: CR H6724)
Sep 14, 2012
Reported by the Committee on Energy and Commerce. H. Rept. 112-673.
Sep 14, 2012
Placed on the Union Calendar, Calendar No. 485.
Jul 27, 2012
Referred to the Subcommittee on Energy and Power.
Jul 25, 2012
Referred to the House Committee on Energy and Commerce.
Jul 25, 2012
Introduced in House
 Votes taken on this bill 1
DateChamberWhat was voted onResultYes–No
Dec 12, 2012 House · vote #623 On Motion to Suspend the Rules and Pass Failed 229–182 See who voted →
 Plain-English summary Congressional Research Service

(This measure has not been amended since it was introduced. The summary of that version is repeated here.)

Asthma Inhalers Relief Act of 2012 - Directs the Administrator of the Environmental Protection Agency (EPA) to: (1) permit the distribution, sale, and consumption in the United States of remaining inventories of CFC epinephrine inhalers manufactured pursuant to the exception for medical devices under the Clean Air Act; (2) not take any enforcement action or otherwise seek to restrict the distribution, sale, or consumption of such inhalers on the basis of any federal law implementing the Montreal Protocol on Substances that Deplete the Ozone Layer; and (3) issue, in response to a request of any distributor or seller of such inhalers, a No Action Assurance Letter stating that the EPA will not initiate an enforcement action relating to the distribution or sale of any such inhaler occurring prior to August 1, 2013.

Defines "CFC epinephrine inhaler" to mean any epinephrine inhaler containing chlorofluorocarbons that was manufactured and classified as over-the-counter before January 1, 2012.

Terminates this Act on August 1, 2013.

What's happening now December 12, 2012

On motion to suspend the rules and pass the bill Failed by the Yeas and Nays: (2/3 required): 229 - 182 (Roll no. 623).

 Committees of jurisdiction 2
 Cosponsors 1
All 1 Republican 1